Chinese Stock Message Board

Stock discussion boards for Japanese, US and Chinese stocks

日本語English简体中文 繁體中文

HOME Monologue Trades Monthly Annual Dividends Stock Assets Total Assets Stock Lending IPO FUNDINNO Indicators Market Daily JP Stock Blog CN Stock Blog US Stock Blog JP Curated Dividends US Curated Dividends CN Curated Dividends 日本株テンバガー候補 JP Top 50 Gainers JP Top 50 Losers JP Stock Board US Stock Board CN Stock Board J-REIT Ranking J-REIT Guide High-Div Funds Yutai Benefits Premium Yutai Club Nikkei A/D Ratio Growth A/D Ratio Investor Flows JP Disclosures US Disclosures CN Disclosures Amazonおすすめ Amazonタイムセール Kabutaro on X

688506 Sichuan Biokin Pharmaceutical Co., Ltd.百利天恒Shanghai Stock Exchange

12 posts

Price chart ・ Find other stocks ・ Japanese version

Sichuan Biokin Pharmaceutical Co., Ltd. (688506) at a glance

Code
688506
Company
Sichuan Biokin Pharmaceutical Co., Ltd.
Local name
百利天恒
Market
Shanghai Stock Exchange
Share price
CN¥253.50 -14.00 (-5.23%) Oct 26 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Sichuan Biokin Pharmaceutical Co., Ltd. (688506) Stock Price History

Sichuan Biokin Pharmaceutical Co., Ltd. closed at CN¥253.50 on Oct 26, 2026, +5.9% over 1 month, −28.0% over 1 year.

2026-09-28 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用BL-M12D1（ADC）…2026-09-30 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC… / 役員の選任 四川百利天恒药业股份有限公司关于聘任证券事务代表的公告2026-10-12 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-16 社債・短期資金調達 四川百利天恒药业股份有限公司关于2026年度第一期科技创新债券发…2026-10-23 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-26 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于T-Bren（HER2 ADC）治疗… / 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于“伦康依隆妥单抗”（iza-…CN¥267.50CN¥226.49Sep 28Oct 26
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥267.50Oct 23
1-Month LowCN¥226.49Oct 14
1-Week Change+6.5%vs Oct 19
1-Month Change+5.9%vs Sep 24

If you had invested CN¥10,000 1 month ago, it would be worth CN¥10,583 today (+5.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −3.3%, while this stock moved +5.8%.

Last 10 Trading Days

DateCloseChange% Change
Oct 26 (Mon)CN¥253.50−14.00−5.23%
Oct 23 (Fri)CN¥267.50+14.50+5.73%
Oct 22 (Thu)CN¥253.00+0.90+0.36%
Oct 21 (Wed)CN¥252.10−1.13−0.45%
Oct 20 (Tue)CN¥253.23+15.23+6.40%
Oct 19 (Mon)CN¥238.00+4.12+1.76%
Oct 16 (Fri)CN¥233.88+2.71+1.17%
Oct 15 (Thu)CN¥231.17+4.68+2.07%
Oct 14 (Wed)CN¥226.49−0.11−0.05%
Oct 13 (Tue)CN¥226.60−1.40−0.61%
2026-09-14 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC…2026-09-18 対外投資 中信证券关于四川百利天恒药业股份有限公司与关联人共同投资的核查意见 / 対外投資 四川百利天恒药业股份有限公司与关联人共同投资公告2026-09-22 契約の締結 四川百利天恒药业股份有限公司自愿披露关于全资子公司SystImmune与百时美…2026-09-28 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用BL-M12D1（ADC）…2026-09-30 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC… / 役員の選任 四川百利天恒药业股份有限公司关于聘任证券事务代表的公告2026-10-12 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-16 社債・短期資金調達 四川百利天恒药业股份有限公司关于2026年度第一期科技创新债券发…2026-10-23 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-26 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于T-Bren（HER2 ADC）治疗… / 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于“伦康依隆妥单抗”（iza-…CN¥322.22CN¥226.49Jul 27Oct 26
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥322.22Jul 29
3-Month LowCN¥226.49Oct 14
1-Month Change+5.9%vs Sep 24
3-Month Change−18.5%vs Jul 24

If you had invested CN¥10,000 3 months ago, it would be worth CN¥8,093 today (−19.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.2%, while this stock moved −19.1%.

Last 10 Trading Days

DateCloseChange% Change
Oct 26 (Mon)CN¥253.50−14.00−5.23%
Oct 23 (Fri)CN¥267.50+14.50+5.73%
Oct 22 (Thu)CN¥253.00+0.90+0.36%
Oct 21 (Wed)CN¥252.10−1.13−0.45%
Oct 20 (Tue)CN¥253.23+15.23+6.40%
Oct 19 (Mon)CN¥238.00+4.12+1.76%
Oct 16 (Fri)CN¥233.88+2.71+1.17%
Oct 15 (Thu)CN¥231.17+4.68+2.07%
Oct 14 (Wed)CN¥226.49−0.11−0.05%
Oct 13 (Tue)CN¥226.60−1.40−0.61%
2026-09-14 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC…2026-09-18 対外投資 中信证券关于四川百利天恒药业股份有限公司与关联人共同投资的核查意见 / 対外投資 四川百利天恒药业股份有限公司与关联人共同投资公告2026-09-22 契約の締結 四川百利天恒药业股份有限公司自愿披露关于全资子公司SystImmune与百时美…2026-09-28 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用BL-M12D1（ADC）…2026-09-30 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC… / 役員の選任 四川百利天恒药业股份有限公司关于聘任证券事务代表的公告2026-10-12 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-16 社債・短期資金調達 四川百利天恒药业股份有限公司关于2026年度第一期科技创新债券发…2026-10-23 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-26 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于T-Bren（HER2 ADC）治疗… / 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于“伦康依隆妥单抗”（iza-…CN¥341.70CN¥204.58Apr 27Oct 26
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥341.70Jul 21
6-Month LowCN¥204.58Jun 8
3-Month Change−18.5%vs Jul 24
6-Month Change−10.8%vs Apr 24

If you had invested CN¥10,000 6 months ago, it would be worth CN¥8,910 today (−10.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.5%, while this stock moved −10.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥253.50+4.8%
Sep 2026CN¥242.00−9.3%
Aug 2026CN¥266.84−10.5%
Jul 2026CN¥298.00+1.4%
Jun 2026CN¥294.03+23.2%
May 2026CN¥238.57−12.5%
Apr 2026CN¥272.74−1.9%
2026-09-14 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC…2026-09-18 対外投資 中信证券关于四川百利天恒药业股份有限公司与关联人共同投资的核查意见 / 対外投資 四川百利天恒药业股份有限公司与关联人共同投资公告2026-09-22 契約の締結 四川百利天恒药业股份有限公司自愿披露关于全资子公司SystImmune与百时美…2026-09-28 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用BL-M12D1（ADC）…2026-09-30 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC… / 役員の選任 四川百利天恒药业股份有限公司关于聘任证券事务代表的公告2026-10-12 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-16 社債・短期資金調達 四川百利天恒药业股份有限公司关于2026年度第一期科技创新债券发…2026-10-23 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单…2026-10-26 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于T-Bren（HER2 ADC）治疗… / 新薬・製品の承認 四川百利天恒药业股份有限公司自愿披露关于“伦康依隆妥单抗”（iza-…CN¥388.28CN¥204.58Oct 27Oct 26
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥388.28Nov 25
52-Week LowCN¥204.58Jun 8
Year to Date−21.5%vs Dec 31
From 52-Week High−34.7%Nov 25

If you had invested CN¥10,000 1 year ago, it would be worth CN¥7,161 today (−28.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −7.5%, while this stock moved −28.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥253.50+4.8%
Sep 2026CN¥242.00−9.3%
Aug 2026CN¥266.84−10.5%
Jul 2026CN¥298.00+1.4%
Jun 2026CN¥294.03+23.2%
May 2026CN¥238.57−12.5%
Apr 2026CN¥272.74−1.9%
Mar 2026CN¥278.00+5.1%
Feb 2026CN¥264.60−4.7%
Jan 2026CN¥277.75−14.0%
Dec 2025CN¥323.10−14.9%
Nov 2025CN¥379.49+1.7%
Oct 2025CN¥372.98―
CN¥388.02CN¥88.80Oct 30, 2023Oct 26, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥388.02Sep 1, 2025
3-Year LowCN¥88.80Oct 30, 2023
Annualized Return+42.0%
Max Drawdown−45.3%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥28,547 today (+185.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +22.0%, while this stock moved +185.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥253.50−21.5%
2025CN¥323.10―
CN¥388.02CN¥32.05Jan 2, 2023Oct 26, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥388.02Sep 1, 2025
5-Year LowCN¥32.05Jan 2, 2023
Annualized Return+72.0%
Max Drawdown−45.3%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥79,095 today (+691.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +17.1%, while this stock moved +691.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥253.50−21.5%
2025CN¥323.10―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2023). Please check the latest prices before trading.

Recent announcements (CNINFO, in Chinese)

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.12 Disclosure 2026/10/26 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于“伦康依隆妥单抗”（iza-bren）治疗EGFR-TKI耐药EGFR突变的局部晚期或转移性非鳞状非小细胞肺癌（二线）的药品上市申请获得受理的公告

📄 Open the filing

Delete
No.11 Disclosure 2026/10/26 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于T-Bren（HER2 ADC）治疗经曲妥珠单抗和紫杉烷类治疗失败的不可切除局部晚期或转移性HER2阳性乳腺癌III期临床试验的期中分析达到主要终点的公告

📄 Open the filing

Delete
No.10 Disclosure 2026/10/23 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单抗，BL-B01D1/iza-bren）治疗局部晚期、复发或转移性HR+HER2-乳腺癌的药品上市申请获得受理的公告

📄 Open the filing

Delete
No.9 Disclosure 2026/10/16 09:00
社債・短期資金調達
四川百利天恒药业股份有限公司关于2026年度第一期科技创新债券发行结果的公告

📄 Open the filing

Delete
No.8 Disclosure 2026/10/12 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于宜泽康?（伦康依隆妥单抗，BL-B01D1/iza-bren）联合放疗治疗局部晚期不可切除头颈鳞癌及其他实体瘤获得药物临床试验批准通知书的公告

📄 Open the filing

Delete
No.7 Disclosure 2026/09/30 09:00
役員の選任
四川百利天恒药业股份有限公司关于聘任证券事务代表的公告

📄 Open the filing

Delete
No.6 Disclosure 2026/09/30 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC）治疗HER2表达的铂耐药复发上皮性卵巢癌、输卵管癌及原发腹膜癌的III期临床试验完成首例受试者入组的公告

📄 Open the filing

Delete
No.5 Disclosure 2026/09/28 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于注射用BL-M12D1（ADC）治疗血液系统恶性肿瘤获得药物临床试验批准通知书的公告

📄 Open the filing

Delete
No.4 Disclosure 2026/09/22 09:00
契約の締結
四川百利天恒药业股份有限公司自愿披露关于全资子公司SystImmune与百时美施贵宝就宜泽康?（伦康依隆妥单抗，BL-B01D1/iza-bren）的全球战略合作协议触发里程碑付款条件的公告

📄 Open the filing

Delete
No.3 Disclosure 2026/09/18 09:00
対外投資
四川百利天恒药业股份有限公司与关联人共同投资公告

📄 Open the filing

Delete
No.2 Disclosure 2026/09/18 09:00
対外投資
中信证券关于四川百利天恒药业股份有限公司与关联人共同投资的核查意见

📄 Open the filing

Delete
No.1 Disclosure 2026/09/14 09:00
新薬・製品の承認
四川百利天恒药业股份有限公司自愿披露关于注射用T-Bren（HER2 ADC）在HER2阳性乳腺癌新辅助治疗的III期临床试验完成首例受试者入组的公告

📄 Open the filing

Delete

Write on the Sichuan Biokin Pharmaceutical Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English